SCHEMBL23580907

SCHEMBL23580907

COc1cc(/C=C/c2cc(O)cc(N)c2CC=C(C)C)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.54
CYP19A1 P11511 4/20 0.52
PTGS2 P35354 4/20 0.52
ALOX5 P09917 4/20 0.52
PTGS1 P23219 2/20 0.49
APP P05067 6/20 0.48
NFE2L2 Q16236 2/20 0.47
TYR P14679 2/20 0.46
PTGES O14684 2/20 0.46
MAOA P21397 2/20 0.45
MAOB P27338 2/20 0.45
MAPT P10636 2/20 0.45
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
TSHR P16473 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
HDAC3 O15379 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23580912 1.00 TTR (0.54) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL30279790 1.00 TTR (0.54) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL25612473 0.92 APP (0.52) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL17201745 0.90 TTR (0.58) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL17201735 0.90 TTR (0.58) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL13824960 0.90 TTR (0.58) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL17201734 0.90 TTR (0.58) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL30279751 0.90 TTR (0.58) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL25612098 0.87 TTR (0.56) TTRCYP19A1PTGS2ALOX5PTGS1
SCHEMBL28917374 0.86 CYP19A1 (0.52) TTRCYP19A1PTGS2ALOX5PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459883-B2 Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof Kynan Duke IP, LLC (US) 2025-11-04 US disclosed
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US disclosed
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US disclosed
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US disclosed
CN-115485259-A Substituted hydroxystilbene compounds and derivatives, synthesis and use thereof 凯楠公爵IP有限责任公司 2022-12-16 CN disclosed
WO-2021127743-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2021-07-01 WO disclosed
WO-2021127743-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12459883-B2 Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof CYP8B1, HSD11B1, HSD11B2 TTR 2074/4885CYP19A1 300/4885PTGS2 213/4885
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF CYP8B1, HSD11B1, HSD11B2 TTR 2074/4885CYP19A1 300/4885PTGS2 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.